Ugo Lucca

Summary

Affiliation: Istituto di Ricerche Farmacologiche Mario Negri
Country: Italy

Publications

  1. ncbi A Population-based study of dementia in the oldest old: the Monzino 80-plus study
    Ugo Lucca
    Laboratory of Geriatric Neuropsychiatry, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy
    BMC Neurol 11:54. 2011
  2. ncbi Association of mild anemia with cognitive, functional, mood and quality of life outcomes in the elderly: the "Health and Anemia" study
    Ugo Lucca
    Laboratory of Geriatric Neuropsychiatry, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy
    PLoS ONE 3:e1920. 2008
  3. ncbi Association of mild anemia with hospitalization and mortality in the elderly: the Health and Anemia population-based study
    Emma Riva
    Laboratory of Geriatric Neuropsychiatry, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy
    Haematologica 94:22-8. 2009
  4. ncbi Prevalence, incidence and types of mild anemia in the elderly: the "Health and Anemia" population-based study
    Mauro Tettamanti
    Laboratory of Geriatric Neuropsychiatry, Istituto di Ricerche Farmacologiche Mario Negri, Via Giuseppe La Masa 19, 20156 Milan, Italy
    Haematologica 95:1849-56. 2010
  5. ncbi Low folate and the risk of cognitive and functional deficits in the very old: the Monzino 80-plus study
    Mauro Tettamanti
    Laboratory of Geriatric Neuropsychiatry, Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milano, Italy
    J Am Coll Nutr 25:502-8. 2006
  6. ncbi Use and misuse of antipsychotic drugs in patients with dementia in Alzheimer special care units
    Alessandro Nobili
    Laboratory of Quality Assessment of Geriatric Therapies and Services, Istituto di Ricerche Farmacologiche Mario Negri, Via Giuseppe La Masa 19, Milan 20156, Italy
    Int Clin Psychopharmacol 24:97-104. 2009
  7. ncbi The serotonin transporter promoter polymorphic region is not a risk factor for Alzheimer's disease related behavioral disturbances
    Diego Albani
    Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Milan, Italy
    J Alzheimers Dis 18:125-30. 2009
  8. ncbi The effect of a structured intervention on caregivers of patients with dementia and problem behaviors: a randomized controlled pilot study
    Alessandro Nobili
    Geriatric Neuropsychiatry Laboratory, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    Alzheimer Dis Assoc Disord 18:75-82. 2004
  9. ncbi Role of VEGF gene variability in longevity: a lesson from the Italian population
    Roberto Del Bo
    Department of Neurological Sciences, Dino Ferrari Centre, University of Milan, IRCCS Foundation Ospedale Maggiore Policlinico, Mangiagalli and Regina Elena, Padiglione Ponti, Milano, Italy
    Neurobiol Aging 29:1917-22. 2008
  10. ncbi Drug utilization and polypharmacy in an Italian elderly population: the EPIFARM-elderly project
    Alessandro Nobili
    Laboratory of Quality Assessment of Geriatric Therapies and Services, Mario Negri Institute for Pharmacological Research, Milan, Italy
    Pharmacoepidemiol Drug Saf 20:488-96. 2011

Collaborators

Detail Information

Publications18

  1. ncbi A Population-based study of dementia in the oldest old: the Monzino 80-plus study
    Ugo Lucca
    Laboratory of Geriatric Neuropsychiatry, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy
    BMC Neurol 11:54. 2011
    ....
  2. ncbi Association of mild anemia with cognitive, functional, mood and quality of life outcomes in the elderly: the "Health and Anemia" study
    Ugo Lucca
    Laboratory of Geriatric Neuropsychiatry, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy
    PLoS ONE 3:e1920. 2008
    ..The objective of the present study was to cross-sectionally investigate the association of mild grade anemia with cognitive, functional, mood, and quality of life (QoL) variables in community-dwelling elderly persons...
  3. ncbi Association of mild anemia with hospitalization and mortality in the elderly: the Health and Anemia population-based study
    Emma Riva
    Laboratory of Geriatric Neuropsychiatry, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy
    Haematologica 94:22-8. 2009
    ..The aim of the present population-based study was to prospectively investigate the association of mild grade anemia with hospitalization and mortality...
  4. ncbi Prevalence, incidence and types of mild anemia in the elderly: the "Health and Anemia" population-based study
    Mauro Tettamanti
    Laboratory of Geriatric Neuropsychiatry, Istituto di Ricerche Farmacologiche Mario Negri, Via Giuseppe La Masa 19, 20156 Milan, Italy
    Haematologica 95:1849-56. 2010
    ..The objectives of this study were to estimate the prevalence and incidence of mild grade anemia and to assess the frequency of anemia types in the elderly...
  5. ncbi Low folate and the risk of cognitive and functional deficits in the very old: the Monzino 80-plus study
    Mauro Tettamanti
    Laboratory of Geriatric Neuropsychiatry, Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milano, Italy
    J Am Coll Nutr 25:502-8. 2006
    ....
  6. ncbi Use and misuse of antipsychotic drugs in patients with dementia in Alzheimer special care units
    Alessandro Nobili
    Laboratory of Quality Assessment of Geriatric Therapies and Services, Istituto di Ricerche Farmacologiche Mario Negri, Via Giuseppe La Masa 19, Milan 20156, Italy
    Int Clin Psychopharmacol 24:97-104. 2009
    ..61-3.26). This study found high rate of use of antipsychotics in patients with dementia resident in Alzheimer special care units, frequent associations with other psychotropic medications and a strong correlation with BPSD...
  7. ncbi The serotonin transporter promoter polymorphic region is not a risk factor for Alzheimer's disease related behavioral disturbances
    Diego Albani
    Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Milan, Italy
    J Alzheimers Dis 18:125-30. 2009
    ..We conclude that 5-HTTLPR and rs25531 are not major genetic modulators of BPSD development in AD...
  8. ncbi The effect of a structured intervention on caregivers of patients with dementia and problem behaviors: a randomized controlled pilot study
    Alessandro Nobili
    Geriatric Neuropsychiatry Laboratory, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    Alzheimer Dis Assoc Disord 18:75-82. 2004
    ..The number of families lost to follow-up, the relatively short duration of the study, and the ceiling effect due to the severity of the clinical characteristics of patients probably all partly dilute the observed findings...
  9. ncbi Role of VEGF gene variability in longevity: a lesson from the Italian population
    Roberto Del Bo
    Department of Neurological Sciences, Dino Ferrari Centre, University of Milan, IRCCS Foundation Ospedale Maggiore Policlinico, Mangiagalli and Regina Elena, Padiglione Ponti, Milano, Italy
    Neurobiol Aging 29:1917-22. 2008
    ..These results suggest that VEGF gene variability can be inserted among the genetic factors influencing the lifespan...
  10. ncbi Drug utilization and polypharmacy in an Italian elderly population: the EPIFARM-elderly project
    Alessandro Nobili
    Laboratory of Quality Assessment of Geriatric Therapies and Services, Mario Negri Institute for Pharmacological Research, Milan, Italy
    Pharmacoepidemiol Drug Saf 20:488-96. 2011
    ..To investigate the prescribing patterns and the prevalence of polypharmacy in community-dwelling elderly people, and to analyze the association of chronic medications and number of drug prescriptions with age and sex...
  11. ncbi Cholinesterase inhibitor use in Alzheimer's disease: the EPIFARM-Elderly Project
    Carlotta Franchi
    Laboratory for Quality Assessment of Geriatric Therapies and Services, Mario Negri Institute for Pharmacological Research, Milan, Italy
    Pharmacoepidemiol Drug Saf 20:497-505. 2011
    ....
  12. ncbi Alzheimer special care units compared with traditional nursing home for dementia care: are there differences at admission and in clinical outcomes?
    Alessandro Nobili
    Laboratory of Quality Assessment of Geriatric Therapies and Services for the Elderly, Lombardy Region, Italy
    Alzheimer Dis Assoc Disord 22:352-61. 2008
    ..Studies comparing Alzheimer Special Care Units (ASCUs) with traditional nursing homes (NHs) have reported conflicting results...
  13. ncbi Tumor necrosis factor alpha polymorphism C-850T is not associated with Alzheimer's disease and vascular dementia in an Italian population
    Liana Terreni
    Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milan, Italy
    Neurosci Lett 344:135-7. 2003
    ..The influence of TNF-alpha polymorphism on dementia has not been confirmed in this segment of the Italian population...
  14. ncbi The Italian version of Consortium to Establish a Registry of Alzheimer's Disease (CERAD)
    Ugo Lucca
    Alzheimers Dement 4:310. 2008
  15. ncbi Homocysteine lowering and cognitive performance
    Ugo Lucca
    N Engl J Med 355:1390; author reply 1391. 2006
  16. ncbi Homocysteine and B vitamins in mild cognitive impairment and dementia
    Pierluigi Quadri
    Geriatric Division and Department of Metabolic Diseases, Ospedale Regionale della Beata Vergine, Mendrisio, Switzerland
    Clin Chem Lab Med 43:1096-100. 2005
    ..6). Present reanalysis results suggest that subclinical folate deficiency and hyperhomocysteinemia might predate dementia onset, findings to be confirmed by longitudinal studies...
  17. ncbi Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia
    Pierluigi Quadri
    Memory Clinic, Geriatric Division and Department of Metabolic Diseases, Ospedale Regionale della Beata Vergine, Mendrisio, Switzerland
    Am J Clin Nutr 80:114-22. 2004
    ..Recent epidemiologic studies reappraised the possibility that vascular risk factors might play a role in the pathogenesis not only of vascular dementia (VaD) but also of Alzheimer disease (AD)...
  18. ncbi Peripheral biomarkers of oxidative damage in Alzheimer's disease
    Chiara Chiabrando
    Ann Neurol 53:419-20; author reply 420. 2003